Novolog (Pharm-Up 1966) Ltd (TLV:NVLG)
Israel
· Delayed Price · Currency is ILS · Price in ILA 126.20
-1.80 (-1.41%)
At close: Dec 4, 2025
Novolog (Pharm-Up 1966) Ratios and Metrics
Market cap in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 3, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 645 | 925 | 726 | 1,409 | 1,504 | 1,423 | Upgrade
|
| Market Cap Growth | -19.59% | 27.45% | -48.50% | -6.30% | 5.66% | 81.80% | Upgrade
|
| Enterprise Value | 644 | 904 | 674 | 1,470 | 1,449 | 1,385 | Upgrade
|
| Last Close Price | 1.26 | 1.76 | 1.32 | 2.52 | 2.65 | 2.68 | Upgrade
|
| PE Ratio | 51.98 | 23.39 | - | 29.66 | 35.53 | 35.52 | Upgrade
|
| Forward PE | - | 14.02 | 14.02 | 14.02 | 14.02 | 14.02 | Upgrade
|
| PS Ratio | 0.33 | 0.46 | 0.44 | 0.93 | 1.20 | 1.25 | Upgrade
|
| PB Ratio | 1.68 | 2.42 | 1.83 | 3.03 | 3.50 | 4.81 | Upgrade
|
| P/TBV Ratio | 12.95 | 17.47 | 10.37 | 13.19 | 9.06 | 19.23 | Upgrade
|
| P/FCF Ratio | 10.10 | 6.37 | 4.43 | 16.07 | 28.51 | 43.30 | Upgrade
|
| P/OCF Ratio | 8.31 | 5.84 | 3.63 | 10.62 | 18.03 | 24.34 | Upgrade
|
| EV/Sales Ratio | 0.33 | 0.45 | 0.41 | 0.98 | 1.15 | 1.22 | Upgrade
|
| EV/EBITDA Ratio | 6.75 | 8.47 | 5.01 | 14.40 | 15.81 | 17.29 | Upgrade
|
| EV/EBIT Ratio | 23.00 | 12.43 | 12.50 | 18.90 | 20.87 | 24.07 | Upgrade
|
| EV/FCF Ratio | 10.09 | 6.23 | 4.12 | 16.77 | 27.46 | 42.13 | Upgrade
|
| Debt / Equity Ratio | 0.55 | 0.52 | 0.54 | 0.46 | 0.39 | 0.52 | Upgrade
|
| Debt / EBITDA Ratio | 2.21 | 1.53 | 1.36 | 1.74 | 1.55 | 1.62 | Upgrade
|
| Debt / FCF Ratio | 3.28 | 1.37 | 1.31 | 2.43 | 3.16 | 4.69 | Upgrade
|
| Asset Turnover | 0.63 | 0.69 | 0.63 | 0.64 | 0.56 | 0.52 | Upgrade
|
| Inventory Turnover | 6.06 | 6.53 | 6.74 | 7.07 | 4.97 | 4.26 | Upgrade
|
| Quick Ratio | 0.84 | 0.83 | 0.85 | 0.87 | 0.92 | 0.84 | Upgrade
|
| Current Ratio | 0.96 | 0.96 | 0.96 | 0.98 | 1.03 | 0.99 | Upgrade
|
| Return on Equity (ROE) | 3.29% | 10.54% | -9.15% | 11.38% | 12.35% | 14.50% | Upgrade
|
| Return on Assets (ROA) | 0.55% | 1.56% | 1.29% | 2.06% | 1.94% | 1.66% | Upgrade
|
| Return on Capital (ROIC) | 2.87% | 7.63% | 5.24% | 7.63% | 8.29% | 8.25% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.90% | 12.60% | 8.90% | 11.40% | 11.60% | 12.70% | Upgrade
|
| Earnings Yield | 1.92% | 4.28% | -5.79% | 3.37% | 2.81% | 2.81% | Upgrade
|
| FCF Yield | 9.90% | 15.69% | 22.57% | 6.22% | 3.51% | 2.31% | Upgrade
|
| Dividend Yield | 3.10% | 2.78% | 2.23% | 2.60% | 3.54% | 0.97% | Upgrade
|
| Payout Ratio | 161.25% | 101.17% | - | 67.14% | 75.62% | 29.95% | Upgrade
|
| Buyback Yield / Dilution | -0.02% | 0.04% | 0.94% | -0.14% | -9.08% | -22.05% | Upgrade
|
| Total Shareholder Return | 3.08% | 2.82% | 3.18% | 2.46% | -5.54% | -21.09% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.